Kalyan Roy: The Oxygen Delivery Paradox in Polycythaemia Vera
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
“The Oxygen Delivery Paradox in Polycythaemia Vera (PV)
At first glance, a higher hematocrit appears beneficial because it increases red blood cell mass and total oxygen content. However, the physiology is more complex.
What Happens When Hematocrit Rises?
- Increased hematocrit or increased red blood cell mass
- Leads to Increased Blood Viscosity
- Which leads to Reduced microcirculatory blood flow
- Which results in Reduced tissue perfusion and oxygen delivery
- Leading to Increased endothelial activation
- Which increases The risk of arterial and venous thrombosis
Key Message
More RBCs mean More Oxygen Content
But not necessarily better oxygen delivery
As blood becomes more viscous, capillary flow and tissue perfusion decline. The result is a paradox where oxygen content rises while oxygen delivery to tissues may actually fall.
Clinical Relevance in PV
- Hyperviscosity is a major driver of symptoms and thrombosis.
- Maintaining hematocrit lower than 45% improves microcirculatory flow and reduces thrombotic complications.
- The goal of treatment is not simply to lower hematocrit, but to optimize tissue oxygen delivery and vascular health.
In Polycythaemia Vera, the problem is often not oxygen carrying capacity – it is impaired oxygen delivery due to hyperviscosity.”
Find more posts featuring Kalyan Roy on Hemostasis Today.
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer